Stockreport

Immunic Highlights 2025 Accomplishments and Upcoming Milestones [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF – Phase 2 CALLIPER Data Showed Vidofludimus Calcium Reduced 24-Week Confirmed Disability Worsening and Increased 24-Week Confirmed Disability Improvement Across Progres [Read more]